Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial

CONCLUSIONS: Although benralizumab resulted in near-complete depletion of blood eosinophils, there was no clinical benefit over placebo.PMID:38367194 | DOI:10.1093/bjd/ljae067

Source: The British Journal of Dermatology - February 17, 2024 Category: Dermatology Authors: Sabine Altrichter Ana Maria Gim énez-Arnau Jonathan A Bernstein Martin Metz Lila Bahadori Maria Bergquist Laura Brooks Calvin N Ho Priya Jain Pradeep B Lukka Eva Rodriguez-Su árez Claire Walton Catherine J Datto ARROYO Study Investigators Source Type: research